-
Product Insights
Saint Luke’s Health Sys – Kansas City East Hospital Expansion – Missouri
The Saint Luke's Health Sys – Kansas City East Hospital Expansion – Missouri involves the expansion of the 5,759m2 East Hospital in Kansas City, Missouri, the US. Equip yourself with the essential tools needed to make informed and profitable decisions with our Saint Luke's Health Sys – Kansas City East Hospital Expansion – Missouri report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the...
-
Product Insights
Alder Hey – Alder Hey Children’s Hospital Expansion – Liverpool
The Alder Hey – Alder Hey Children's Hospital Expansion – Liverpool involves the construction of a new Surgical Neonatal Intensive Care Unit (NICU) in Liverpool, the UK. Equip yourself with the essential tools needed to make informed and profitable decisions with our Alder Hey – Alder Hey Children's Hospital Expansion – Liverpool report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding...
-
Product Insights
Jackson MH – Jackson Memorial Hospital’s Emergency Department Expansion – Florida
The Jackson MH – Jackson Memorial Hospital's Emergency Department Expansion – Florida involves the expansion of two-story, 12,077m2 Jackson Memorial Hospital's emergency department with 200 beds in Jackson, Florida, the US. Equip yourself with the essential tools needed to make informed and profitable decisions with our Jackson MH – Jackson Memorial Hospital's Emergency Department Expansion – Florida report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business...
-
Product Insights
Timone Hosp – Marseille Timone University Hospitals Expansion And Rehabilitation Program: SAMU Building – Provence-Alpes-Cote d’Azur
The Timone Hosp – Marseille Timone University Hospitals Expansion And Rehabilitation Program: SAMU Building – Provence-Alpes-Cote d'Azur involves the construction of the 532-room SAMU building on a 56,000m2 floor area in Marseille, Bouches-du-Rhône Department, Provence-Alpes-Côte d'Azur Region, France. Equip yourself with the essential tools needed to make informed and profitable decisions with our Timone Hosp – Marseille Timone University Hospitals Expansion And Rehabilitation Program: SAMU Building – Provence-Alpes-Cote d'Azur report. Note: This is an on-demand report that will be delivered...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Hospital Acquired Pneumonia (HAP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Avibactam + Aztreonam) in Hospital Acquired Pneumonia (HAP) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Hospital Acquired Pneumonia (HAP)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SR-1375 in Hospital Acquired Pneumonia (HAP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SR-1375 in Hospital Acquired Pneumonia (HAP) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SR-1375 in Hospital Acquired Pneumonia (HAP) Drug Details: SR-1375 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (KSP-1007 + Meropenem) in Hospital Acquired Pneumonia (HAP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (KSP-1007 + Meropenem) in Hospital Acquired Pneumonia (HAP) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (KSP-1007 + Meropenem) in Hospital Acquired Pneumonia (HAP)...
-
Product Insights
Chiba – Chiba City New Hospital Development – Chiba
The Chiba – Chiba City New Hospital Development – Chiba involves the construction of a 38,834.59m2, 30.65m-tall, five-story, 349 beds hospital on 3.49ha of land in Chiba City, Chiba Prefecture, Japan. Equip yourself with the essential tools needed to make informed and profitable decisions with our Chiba – Chiba City New Hospital Development – Chiba report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of...
-
Product Insights
Odawara City – Odawara City New Hospital Development – Kanagawa
The Odawara City – Odawara City New Hospital Development – Kanagawa involves the construction of a 42,226m2, seven-story hospital with 402 beds on 2.3ha of land of land in in Odawara City, Kanagawa Prefecture, Japan.. Equip yourself with the essential tools needed to make informed and profitable decisions with our Odawara City – Odawara City New Hospital Development – Kanagawa report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2...
-
Product Insights
NewHospital Acquired Pneumonia (HAP) – Drugs In Development, 2024
Empower your strategies with our Hospital Acquired Pneumonia (HAP) – Drugs In Development, 2024 report and make more profitable business decisions. Hospital-acquired pneumonia (HAP) is defined as pneumonia acquired during a hospital stay. Symptoms include cough, fever, shaking chills, confusion, headache, and loss of appetite. Risk factors include chronic lung disease, cigarette smoking, dementia, stroke, brain injury, heart disease, liver cirrhosis, and diabetes mellitus. Treatment includes antibiotics and healthy lifestyle. The Hospital Acquired Pneumonia (HAP) drugs in development market research report...